152 related articles for article (PubMed ID: 25833795)
1. Vitamin D status in Well-Controlled Caucasian HIV Patients in Relation to Inflammatory and Metabolic Markers--A Cross-Sectional Cohort Study in Sweden.
Missailidis C; Höijer J; Johansson M; Ekström L; Bratt G; Hejdeman B; Bergman P
Scand J Immunol; 2015 Jul; 82(1):55-62. PubMed ID: 25833795
[TBL] [Abstract][Full Text] [Related]
2. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
Reus Bañuls S; Portilla Sogorb J; Sanchez-Paya J; Boix Martínez V; Giner Oncina L; Frances R; Such J; Merino Lucas E; Gimeno Gascón A
Med Clin (Barc); 2014 Jan; 142(2):47-52. PubMed ID: 24120098
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).
Viladés C; Escoté X; López-Dupla M; Martinez E; Domingo P; Asensi V; Leal M; Peraire J; Inza MI; Arnedo M; Gutiérrez M; Valle-Garay E; Ferrando-Martinez S; Olona M; Alba V; Sirvent JJ; Gatell JM; Vidal F;
J Antimicrob Chemother; 2014 Jun; 69(6):1653-9. PubMed ID: 24535275
[TBL] [Abstract][Full Text] [Related]
5. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
6. High 25-hydroxyvitamin D is associated with unexpectedly high plasma inflammatory markers in HIV patients on antiretroviral therapy.
Gangcuangco LMA; Kohorn LB; Chow DC; Keating SM; Norris PJ; Nagamine LS; Ndhlovu LC; Souza SA; Kallianpur KJ; Shikuma CM
Medicine (Baltimore); 2016 Oct; 95(43):e5270. PubMed ID: 27787390
[TBL] [Abstract][Full Text] [Related]
7. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Hoffman RM; Lake JE; Wilhalme HM; Tseng CH; Currier JS
AIDS Res Hum Retroviruses; 2016 Mar; 32(3):247-54. PubMed ID: 26569649
[TBL] [Abstract][Full Text] [Related]
9. Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Thiébaut R; Charpentier C; Damond F; Taieb A; Antoine R; Capeau J; Chêne G; Collin G; Matheron S; Descamps D; Brun-Vézinet F;
Clin Infect Dis; 2012 Nov; 55(10):1417-25. PubMed ID: 22911639
[TBL] [Abstract][Full Text] [Related]
10. Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood.
Grudet C; Malm J; Westrin A; Brundin L
Psychoneuroendocrinology; 2014 Dec; 50():210-9. PubMed ID: 25240206
[TBL] [Abstract][Full Text] [Related]
11. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.
Leite KME; Santos Júnior GG; Godoi ETAM; Vasconcelos AF; Lorena VMB; Araújo PSR; Lima KO; Lacerda HR
Arq Bras Cardiol; 2020 Jan; 114(1):90-97. PubMed ID: 31664319
[TBL] [Abstract][Full Text] [Related]
14. Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.
Hileman CO; Kinley B; Scharen-Guivel V; Melbourne K; Szwarcberg J; Robinson J; Lederman MM; Mccomsey GA
J Infect Dis; 2015 Aug; 212(3):345-54. PubMed ID: 25583168
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Markers Related to Microbial Translocation Among HIV-Infected Pregnant Women: A Risk Factor of Preterm Delivery.
López M; Figueras F; Coll O; Goncé A; Hernández S; Loncá M; Vila J; Gratacós E; Palacio M
J Infect Dis; 2016 Feb; 213(3):343-50. PubMed ID: 26265778
[TBL] [Abstract][Full Text] [Related]
16. Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy.
Ramayo E; González-Moreno MP; Macías J; Cruz-Ruíz M; Mira JA; Villar-Rueda AM; García-García JA; Gómez-Mateos JM; Lozano F; Pineda JA
AIDS Res Hum Retroviruses; 2005 Nov; 21(11):915-21. PubMed ID: 16386106
[TBL] [Abstract][Full Text] [Related]
17. Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.
Michelini Z; Baroncelli S; Fantauzzi A; Pasquale C; Galluzzo CM; Sanchez M; Gatto M; Amici R; Franco M; d'Ettorre G; Fimiani C; Mezzaroma I; Vullo V; Merli M; Palmisano L
HIV Clin Trials; 2016 Mar; 17(2):49-54. PubMed ID: 26739837
[TBL] [Abstract][Full Text] [Related]
18. Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch.
Tiraboschi JM; Muñoz-Moreno JA; Puertas MC; Alonso-Villaverde C; Prats A; Ferrer E; Rozas N; Maso M; Ouchi D; Martinez-Picado J; Podzamczer D
HIV Med; 2015 Jul; 16(6):388-92. PubMed ID: 25721471
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV-infected adults on a long-term non-nucleoside reverse transcriptase inhibitor-based regimen.
Allavena C; Rodallec A; Sécher S; Reliquet V; Baffoin S; André-Garnier E; Billaud E; Raffi F; Ferré V
J Med Virol; 2013 Nov; 85(11):1878-82. PubMed ID: 23861166
[TBL] [Abstract][Full Text] [Related]
20. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers.
Romero-Sánchez M; González-Serna A; Pacheco YM; Ferrando-Martínez S; Machmach K; García-García M; Alvarez-Ríos AI; Vidal F; Leal M; Ruiz-Mateos E
J Infect; 2012 Nov; 65(5):431-8. PubMed ID: 22728172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
